Data / Form D filings / LevitasBio, Inc.
LevitasBio, Inc.: Form D filings
LevitasBio, Inc., a technology company in Menlo Park, CA, filed 4 Form D notices with the SEC between 2017 and 2024. The latest, on April 10, 2024, reports $11.8 million sold of a $25.1 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1505 ADAMS DRIVE, Suite D, Menlo Park, CA, 94025
- Phone
- (000) 000-0000
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1713509
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 10, 2024 | New notice | $25,059,184 | $11,759,181 | $13,300,003 | 3 | Mar 28, 2024 | sec.gov |
| Oct 26, 2022 | New notice | $34,999,997 | $34,999,997 | 4 | Sep 12, 2022 | sec.gov | |
| Jan 15, 2021 | New notice | $24,011,644 | $19,011,644 | $5,000,000 | 5 | Dec 31, 2020 | sec.gov |
| Aug 3, 2017 | New notice | $8,000,001 | $8,000,001 | 1 | Jul 27, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steve Tablak | Director | |
| Paul Meister | Director | |
| Greg Herrema | Director | |
| Sandy Gardiner | Director | |
| Martin Pieprzyk | Executive Officer, Director | |
| Victor E. Tong, Jr. | Director |
Other technology companies in California that filed recently
- Redwagon Systems Inc. $1.2 million · Oct 30, 2026
- General Compute Inc. $132.2 million · Oct 30, 2026
- Promptiva Health Inc. offering · Oct 30, 2026
- thenevercompany.ai Inc. $200,000 · Oct 29, 2026
- TrashLab Software Inc. $10.7 million · Oct 29, 2026
- Vasopore, Inc. $1.1 million · Oct 28, 2026
Every Form D from the week of Apr 8, 2024 · All recent filings in California · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what LevitasBio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.